A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

HUNTINGTON Jacob Harper, a 23-year-old fighting a rare form of ALS (amyotrophic lateral sclerosis), has become a beacon of hope for many. Diagnosed in 2022 and the youngest person in the state of West ...

NeuroSense plans to apply to Canada’s regulators for early marketing approval of the oral therapy, supported by a Phase 2b ...

NUZ is advancing its lead drug monepantel, now known as NUZ-001, for the treatment of neurodegenerative diseases, starting ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...

Folks came together at Columbia Point Park in Richland Saturday to help raise money and awareness aboutAmyotrophic lateral ...

Sanofi's (SNY) experimental therapy DNL788, developed with Denali Therapeutics (SNLI), fails in second mid-stage trial within ...

Researchers at the Francis Crick Institute and the UCL Queen Square Institute of Neurology have developed DNA molecules which contain "invisibility cloak" sequences, preventing healthy cells from ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

Billings is a world history and social science teacher on the Elk Grove Unified School District campus and has coached the varsity program for three seasons. He announced early this season that he was ...